nmorgen wrote:... Has anyone experienced this? Could it have been the immunotherapy?
In a previous post, nmorgen wrote:...Has anyone heard of this happening?
... Has anyone experienced this?
...Could it have been the immunotherapy?
5.2 Infusion-Related Reactions
Infusion- related reactions occurred in 5% (33/666) of patients who received YERVOY 1 mg/kg with nivolumab for the treatment of RCC or CRC.
OPDIVO 3 mg/kg with Yervoy(ipilimumab) 1 mg/kg
Infusion-related reactions occurred in 5.1% (28/547) of patients with RCC and 4.2% (5/119) of patients with CRC who received OPDIVO 3 mg/kg with ipilimumab 1 mg/kg every 3 weeks, respectively.
Users browsing this forum: pearl and 4 guests